NO975094L - Vinylpyrrolidoncefalosporinderivater - Google Patents
VinylpyrrolidoncefalosporinderivaterInfo
- Publication number
- NO975094L NO975094L NO975094A NO975094A NO975094L NO 975094 L NO975094 L NO 975094L NO 975094 A NO975094 A NO 975094A NO 975094 A NO975094 A NO 975094A NO 975094 L NO975094 L NO 975094L
- Authority
- NO
- Norway
- Prior art keywords
- lower alkyl
- compounds
- hydrogen
- heterocyclyl
- hydroxy
- Prior art date
Links
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 150000002148 esters Chemical class 0.000 abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 229930186147 Cephalosporin Natural products 0.000 abstract 1
- 208000035473 Communicable disease Diseases 0.000 abstract 1
- 229910052783 alkali metal Inorganic materials 0.000 abstract 1
- 150000001340 alkali metals Chemical class 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000004104 aryloxy group Chemical group 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 229940124587 cephalosporin Drugs 0.000 abstract 1
- 150000001780 cephalosporins Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 125000005504 styryl group Chemical group 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/18—7-Aminocephalosporanic or substituted 7-aminocephalosporanic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Photoreceptors In Electrophotography (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96117710 | 1996-11-06 | ||
EP97115996 | 1997-09-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO975094D0 NO975094D0 (no) | 1997-11-05 |
NO975094L true NO975094L (no) | 1998-05-07 |
Family
ID=26142279
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO975094A NO975094L (no) | 1996-11-06 | 1997-11-05 | Vinylpyrrolidoncefalosporinderivater |
Country Status (18)
Country | Link |
---|---|
US (1) | US6294668B1 (es) |
EP (1) | EP0841339B1 (es) |
JP (1) | JP3065289B2 (es) |
KR (1) | KR100273611B1 (es) |
CN (1) | CN1081639C (es) |
AT (1) | ATE354577T1 (es) |
AU (1) | AU727014B2 (es) |
CA (1) | CA2220188C (es) |
CZ (1) | CZ350197A3 (es) |
DE (1) | DE69737382T2 (es) |
DK (1) | DK0841339T3 (es) |
ES (1) | ES2281090T3 (es) |
HU (1) | HUP9701835A3 (es) |
IL (1) | IL122098A0 (es) |
MA (1) | MA26446A1 (es) |
NO (1) | NO975094L (es) |
NZ (1) | NZ329106A (es) |
SG (1) | SG71055A1 (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6150350A (en) * | 1997-09-15 | 2000-11-21 | Hoffman-La Roche Inc. | Antimicrobial compositions |
HUP0105426A3 (en) * | 1998-06-15 | 2002-12-28 | Hoffmann La Roche | Derivatives of 3-(2-oxo-[1,3']bipyrrolidinyl-3-ylidenemethyl)-cephems and pharmaceutical compositions thereof |
US6232306B1 (en) | 1998-06-15 | 2001-05-15 | Hoffmann-La Roche Inc. | Derivatives of 3-(2-oxo-[1,3′]bipyrrolidinyl-3-ylidenemethyl)-cephams |
BR9911445A (pt) | 1998-06-22 | 2001-03-20 | Hoffmann La Roche | Derivados de propenil cefalosporina |
AU1654900A (en) * | 1998-12-03 | 2000-06-19 | F. Hoffmann-La Roche Ag | Bi-pyrrolidinylvinl (carba) cephalosporins |
AU6267100A (en) * | 1999-07-07 | 2001-01-30 | F. Hoffmann-La Roche Ag | Vinylpyrrolidinone derivatives with substituted thiazole ring |
KR101032227B1 (ko) * | 2000-02-15 | 2011-05-02 | 히다치 가세고교 가부시끼가이샤 | 접착제 조성물, 그 제조 방법, 이것을 이용한 접착 필름, 반도체 탑재용 기판 및 반도체 장치 |
WO2006010978A1 (en) * | 2004-06-30 | 2006-02-02 | Wockhardt Limited | Cefdinir polymorphic forms, and imidazole salt |
CA2672267C (en) | 2006-07-27 | 2016-05-31 | Emisphere Technologies, Inc. | Arylsulfanyl compounds and compositions for delivering active agents |
AU2009278929B2 (en) * | 2008-08-04 | 2012-07-05 | Astrazeneca Ab | Pyrazolo [3,4] pyrimidin-4-yl derivatives and their uses to treat diabetes and obesity |
AR076220A1 (es) | 2009-04-09 | 2011-05-26 | Astrazeneca Ab | Derivados de pirazol [4,5 - e] pirimidina |
AR076221A1 (es) | 2009-04-09 | 2011-05-26 | Astrazeneca Ab | Derivado de pirazol [4,5-e] pirimidina y su uso para tratar diabetes y obesidad |
ES2565952T3 (es) | 2009-05-25 | 2016-04-07 | Sandoz Ag | Método para la producción de ceftobiprol medocaril |
UY35103A (es) | 2012-10-29 | 2014-05-30 | Glaxo Group Ltd | Compuestos de cefem 2-sustituidos |
CN111471058A (zh) * | 2019-01-23 | 2020-07-31 | 中国医学科学院药物研究所 | 用于制备头孢吡普类似物的方法 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4255423A (en) * | 1977-07-27 | 1981-03-10 | Merck & Co., Inc. | Cephalosporin compounds |
FR2457296A1 (fr) | 1979-05-23 | 1980-12-19 | Rhone Poulenc Ind | Nouveaux derives de vinyl-3 cephalosporines et leur preparation |
IL94946A0 (en) | 1989-07-13 | 1991-06-10 | Eisai Co Ltd | 3-substituted vinyl cephalosporin derivatives,their preparation and pharmaceutical compositions containing them |
ATE118215T1 (de) | 1989-09-04 | 1995-02-15 | Beecham Group Plc | Cephalosporinderivate, verfahren zu ihrer herstellung, pharmazeutische präparate und zwischenverbindungen. |
KR0174535B1 (ko) | 1989-09-04 | 1999-02-01 | 알렌 제이 스피글 | 베타-락탐 함유 화합물 및 그의 제조방법 |
GB9019743D0 (en) | 1990-09-10 | 1990-10-24 | Beecham Group Plc | Novel compounds |
CA2147609A1 (en) | 1992-10-23 | 1994-05-11 | Kohji Kawabata | Cephem compounds, and their pharmaceutical compositions |
US5523400A (en) | 1993-04-16 | 1996-06-04 | Hoffmann-La Roche Inc. | Cephalosporin antibiotics |
ATE227728T1 (de) * | 1993-04-16 | 2002-11-15 | Basilea Pharmaceutica Ag | Cephalosporin-derivate |
US5827845A (en) | 1993-09-29 | 1998-10-27 | Meiji Seika Kaisha, Ltd. | Cephalosporin derivative |
US5559108A (en) | 1994-09-02 | 1996-09-24 | Bristol-Myers Squibb Company | Cephalosporin derivatives |
US5567698A (en) | 1995-02-15 | 1996-10-22 | Bristol-Myers Squibb Company | Pyridinium thiomethyl substituted chepholosporin derivatives |
AU4877196A (en) * | 1995-02-27 | 1996-09-18 | F. Hoffmann-La Roche Ag | Derivatives of 3-pyrrolidylidene-2-one-cephalosporines |
JPH08319291A (ja) | 1995-05-25 | 1996-12-03 | Meiji Seika Kaisha Ltd | 新規セフェム誘導体 |
AT403161B (de) | 1995-07-19 | 1997-11-25 | Biochemie Gmbh | Verfahren zur herstellung von cephemverbindungen |
EP0761673A1 (en) * | 1995-09-12 | 1997-03-12 | F. Hoffmann-La Roche Ag | Cephalosporin derivatives |
US5883247A (en) | 1996-06-10 | 1999-03-16 | Hoffmann-La Roche Inc. | Preparation of cephem and isooxacephem derivatives |
EP0831093A1 (en) | 1996-09-23 | 1998-03-25 | F. Hoffmann-La Roche Ag | 1-Carba-(dethia)-Cephalosporin Derivatives |
-
1997
- 1997-10-29 ES ES97118780T patent/ES2281090T3/es not_active Expired - Lifetime
- 1997-10-29 DE DE69737382T patent/DE69737382T2/de not_active Expired - Lifetime
- 1997-10-29 AT AT97118780T patent/ATE354577T1/de active
- 1997-10-29 DK DK97118780T patent/DK0841339T3/da active
- 1997-10-29 EP EP97118780A patent/EP0841339B1/en not_active Expired - Lifetime
- 1997-11-03 MA MA24852A patent/MA26446A1/fr unknown
- 1997-11-04 CA CA002220188A patent/CA2220188C/en not_active Expired - Fee Related
- 1997-11-04 NZ NZ329106A patent/NZ329106A/xx unknown
- 1997-11-04 IL IL12209897A patent/IL122098A0/xx unknown
- 1997-11-05 SG SG1997003954A patent/SG71055A1/en unknown
- 1997-11-05 AU AU44356/97A patent/AU727014B2/en not_active Ceased
- 1997-11-05 HU HU9701835A patent/HUP9701835A3/hu unknown
- 1997-11-05 CZ CZ973501A patent/CZ350197A3/cs unknown
- 1997-11-05 KR KR1019970058137A patent/KR100273611B1/ko not_active IP Right Cessation
- 1997-11-05 NO NO975094A patent/NO975094L/no not_active Application Discontinuation
- 1997-11-05 CN CN97122431A patent/CN1081639C/zh not_active Expired - Fee Related
- 1997-11-05 US US08/964,640 patent/US6294668B1/en not_active Expired - Fee Related
- 1997-11-06 JP JP9304115A patent/JP3065289B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
HUP9701835A3 (en) | 2001-04-28 |
EP0841339B1 (en) | 2007-02-21 |
CA2220188A1 (en) | 1998-05-06 |
CZ350197A3 (cs) | 1998-05-13 |
NZ329106A (en) | 1998-12-23 |
CN1181382A (zh) | 1998-05-13 |
CN1081639C (zh) | 2002-03-27 |
AU727014B2 (en) | 2000-11-30 |
ATE354577T1 (de) | 2007-03-15 |
NO975094D0 (no) | 1997-11-05 |
DE69737382D1 (de) | 2007-04-05 |
SG71055A1 (en) | 2000-03-21 |
EP0841339A1 (en) | 1998-05-13 |
JP3065289B2 (ja) | 2000-07-17 |
MA26446A1 (fr) | 2004-12-20 |
JPH10139783A (ja) | 1998-05-26 |
DE69737382T2 (de) | 2007-10-31 |
US6294668B1 (en) | 2001-09-25 |
IL122098A0 (en) | 1998-04-05 |
ES2281090T3 (es) | 2007-09-16 |
KR19980042094A (ko) | 1998-08-17 |
KR100273611B1 (ko) | 2000-12-15 |
AU4435697A (en) | 1998-05-14 |
CA2220188C (en) | 2008-04-08 |
HU9701835D0 (en) | 1997-12-29 |
DK0841339T3 (da) | 2007-07-02 |
HUP9701835A2 (hu) | 1999-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO975094L (no) | Vinylpyrrolidoncefalosporinderivater | |
NO924650L (no) | Dialkoksy-pyridinyl-benzimidazolderivater, fremgangsmaate for deres fremstilling og deres farmasoeytiske anvendelse | |
HUP0303037A2 (hu) | Alzheimer-kór kezelésére alkalmas vegyületek és ezeket tartalmazó gyógyszerkészítmények | |
HUP0101595A2 (hu) | 3-(Amino- vagy amino-alkil)-piridinon-származékok, eljárás előállításukra és alkalmazásuk HIV-vel kapcsolatos betegségek kezelésére szolgáló gyógyszerkészítmények előállítására, valamint a vegyületeket tartalmazó gyógyszerkészítmények | |
HUP0204246A2 (hu) | Új tiazolo[4,5-d]pirimidin-származékok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
HUP0101999A2 (hu) | 4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása | |
HUP0402225A2 (hu) | Makrolid-vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
DE69505542D1 (de) | 3-benzoylbenzofuran-derivate als thyroidhormonantagonisten | |
ES2123652T3 (es) | 7-(2-aminoetil)-benzotiazolonas. | |
UA26368A (uk) | Спосіб одержаhhя похідhих оксадіазолалкілпуриhу або їх фармацевтичhо прийhятhих кислотhо-адитивhих солей (варіаhти) | |
BR9812239A (pt) | Composto, formulação farmacêutica, uso do composto, processos para o tratamento de distúrbios, para o tratamento de distúrbios mediados por 5-hidroxitriptamina, e, para a preparação do composto | |
DK46987A (da) | Dihydrobenzofuran- og chromancarboxamidderivater, fremgangsmaade til fremstilling deraf og laegemiddel indeholdende saadanne derivater samt mellemprodukter til brug ved deres fremstilling | |
ES2060303T3 (es) | Derivados de piperidiloxiisoxazol y quinuclidiniloxiisoxazol, su preparacion y su uso terapeutico. | |
AR031486A1 (es) | Derivados de pirimidina | |
NO961797L (no) | Anvendelse av benzopyranderivater for fremstilling av farmasöytiske sammensetninger beregnet for behandling av patologier forbundet med den Na+-uavhengige C1-HCO3-utbytter | |
DK148288A (da) | N-phenethylaminoalkyl-benzamid-forbindelser, deres anvendelse til fremstilling af antiarrhythmia-laegemidler og farmaceutiske praeparater indeholdende forbindelserne | |
DK0458234T3 (da) | 3-[1-Thiazolidinylbutyl-4-piperazinyl]-1H-indazoler, en fremgangsmåde til deres fremstilling og deres anvendelse som lægemi | |
DE69518706D1 (de) | Verwendung von Diphenylethanderivaten zur Herstellung eines Arzneimittels zur Behandlung von Glaukom | |
NO170274C (no) | Analogifremgangsmaate for fremstilling av nye terapeutisk virksomme benzhydryloksyetylpiperidin-derivater | |
NO954538L (no) | N-p-halobenzoylmetylderivater av 4-(p-fluorfenyl)-3-((3,4-metylendioksy)fenoksy)metyl)piperidin | |
ATE37368T1 (de) | Benzothiazolon-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
DE69110217T2 (de) | Derivate der Kaffeinsäure und sie enthaltende pharmazeutische Zusammensetzungen. | |
FI823732L (fi) | Nya 1-furyl-3,4-dihydroisokinoliner, laekemedel innehaollande dessa samt deras framstaellningsfoerfaranden och deras anvaendning | |
NO20020475L (no) | 2-aminotetralinderivater for terapi av glaukom | |
MX9708525A (es) | Derivados de vinilpirrolidinon-cefalosporina. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |